EDESA BIOTECH, INC. Current Assets
EDESA BIOTECH, INC. (EDSA) had Current Assets of $10.78 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-13
- 2026-06-30: Assets, Current $10.78M.
- 2026-03-31: Assets, Current $10.42M.
- 2025-12-31: Assets, Current $12.72M.
- 2025-09-30: Assets, Current $11.51M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $10.78M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $10.42M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $12.72M 10-Q · filed 2026-02-13 | |
| 2025-09-30 | $11.51M 10-Q · filed 2026-08-13 | |
| 2025-06-30 | $12.76M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $14.39M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $2.07M 10-Q · filed 2025-02-14 | |
| 2024-09-30 | $1.68M 10-K · filed 2025-12-12 | |
| 2024-06-30 | $3.05M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $4.24M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $5.42M 10-Q · filed 2024-02-09 | |
| 2023-09-30 | $6.44M 10-K · filed 2024-12-13 | |
| 2023-06-30 | $6.91M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $8.13M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $9.09M 10-Q · filed 2023-02-10 | |
| 2022-09-30 | $9.09M 10-K · filed 2023-12-15 | |
| 2022-06-30 | $15.18M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $18.00M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $9.89M 10-Q · filed 2022-02-14 | |
| 2021-09-30 | $12.09M 10-K · filed 2022-12-16 | |
| 2021-06-30 | $14.33M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $21.42M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $7.67M 10-Q · filed 2021-02-16 | |
| 2020-09-30 | $8.10M 10-K · filed 2021-12-28 | |
| 2020-06-30 | $6.22M 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $7.43M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $4.83M 10-Q · filed 2020-02-13 | |
| 2019-09-30 | $5.64M 10-K · filed 2020-12-07 | |
| 2019-06-30 | $7.12M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $8.14M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $3.39M 10-KT · filed 2019-12-12 | $9.46M 10-Q · filed 2019-02-05 |
| 2018-09-30 | $10.66M 10-Q · filed 2019-05-08 | |
| 2018-06-30 | $11.63M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $4.27M 10-Q · filed 2018-05-07 | |
| 2017-12-31 | $5.66M 10-Q · filed 2018-02-07 | |
| 2017-09-30 | $6.76M 10-K · filed 2018-11-30 | |
| 2017-06-30 | $8.12M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $9.35M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $10.59M 10-Q · filed 2017-02-06 | |
| 2016-09-30 | $12.10M 10-K · filed 2017-12-01 | |
| 2016-06-30 | $7.73M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $8.72M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $9.69M 10-Q · filed 2016-02-08 | |
| 2015-09-30 | $9.87M 10-K · filed 2016-12-14 | |
| 2015-06-30 | $10.73M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $11.44M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $13.02M 10-Q · filed 2015-02-09 | |
| 2014-09-30 | $14.42M 10-K · filed 2015-12-14 | |
| 2014-08-31 | $14.07M 10-K · filed 2015-12-14 | |
| 2013-08-31 | $8.13M 10-K · filed 2014-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |